Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Equity Average (2023 - 2025)

Cannabis Bioscience International Holdings' Equity Average history spans 3 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Equity Average fell 19.14% year-over-year to -$1.3 million; the TTM value through Nov 2025 reached -$1.3 million, down 19.14%, while the annual FY2025 figure was -$1.1 million, 34.23% down from the prior year.
  • Equity Average for Q4 2025 was -$1.3 million at Cannabis Bioscience International Holdings, down from -$1.2 million in the prior quarter.
  • Across five years, Equity Average topped out at -$443479.5 in Q1 2023 and bottomed at -$1.3 million in Q4 2025.
  • The 3-year median for Equity Average is -$1.0 million (2024), against an average of -$949797.5.
  • The largest annual shift saw Equity Average tumbled 104.97% in 2024 before it decreased 12.91% in 2025.
  • A 3-year view of Equity Average shows it stood at -$779673.0 in 2023, then crashed by 40.45% to -$1.1 million in 2024, then dropped by 19.14% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Equity Average are -$1.3 million (Q4 2025), -$1.2 million (Q3 2025), and -$1.2 million (Q2 2025).